Pacific Biosciences Of California reported $2.53B in Market Capitalization this January of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Accelerate Diagnostics AXDX:US 0.36B 0.13B
Agilent A:US $ 47.69B 2.84B
Bruker BRKR:US $ 11.79B 0.28B
Danaher DHR:US $ 217.34B 25.92B
Fluidigm FLDM:US $ 0.5B 0.04B
General Electric GE:US $ 113.14B 5.06B
Genmark Diagnostics GNMK:US $ 1.05B 0.04B
Illumina ILMN:US $ 63.48B 5.61B
Luminex LMNX:US $ 1.51B 0.43B
Myriad Genetics MYGN:US $ 2.52B 0.16B
Nanostring Technologies NSTG:US $ 2.19B 0.74B
Oxford Immunotec Global OXFD:US 0.3B 0.03B
Pacific Biosciences Of California PACB:US $ 5.08B 1.85B
Perkinelmer PKI:US $ 19.43B 2.12B
Quidel QDEL:US $ 5.88B 0.42B
Thermo Fisher Scientific TMO:US $ 224.77B 26.5B
Waters WAT:US $ 21.93B 0.6B